Central nervous system leukemia and solid tumors of childhood. Treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU).
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002813:Chondrosarcoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008637:Mesenchymoma / Q000188:drug therapy*; D008654:Mesothelioma / Q000188:drug therapy*; D009447:Neuroblastoma / Q000188:drug therapy*; D009603:Nitroso Compounds / Q000627:therapeutic use*; D011654:Pulmonary Edema / Q000209:etiology; D013902:Radiography, Thoracic; D012512:Sarcoma, Ewing / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000209:etiology; D009396:Wilms Tumor / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009603:Nitroso Compounds